Again, there are two important points here.
First is that, in a Canadian context, the decision by the WHO would not affect our ability to distribute and approve the vaccine. In fact, the vaccine was approved for use in Canada in February 2022. That's point one.
For point two, I very much feel that if Medicago had been the only viable option in front of it, the WHO would have made a different decision. The decision the WHO made at that point in time was based on a moment in time when not only was it not on the ancestral strain but it was on the evolved strain of the coronavirus, and a bevy—a wide range—of vaccines were available.